GLYPICAN-3 PROMOTES HEPATOCELLULAR CARCINOMA PROGRESSION AND METASTASIS BY ACTIVATION OF THE ERK SIGNALING PATHWAY

被引：0
|
作者：
Wu, Y. [1 ]
Liu, H. [1 ]
Weng, H. [2 ]
Zhang, X. [1 ]
Li, P. [1 ]
Fan, C. [1 ]
Li, B. [1 ]
Dong, P. [1 ]
Li, L. [1 ]
Dooley, S. [2 ]
Ding, H. [1 ]
机构：
[1] Capital Med Univ, Beijing Youan Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China
[2] Univ Med Ctr Mannheim, Mol Hepatol, Mannheim, Germany
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30537-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0322
引用
收藏
页码：S429 / S430
页数：2
相关论文
共 50 条
  • [1] Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway
    Wu, Yongle
    Liu, Hui
    Weng, Honglei
    Zhang, Xin
    Li, Peng
    Fan, Chun-Lei
    Li, Bing
    Dong, Pei-Ling
    Li, Lei
    Dooley, Steven
    Ding, Hui-Guo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 1275 - 1285
  • [2] Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
    Capurro, MI
    Xiang, YY
    Lobe, C
    Filmus, J
    CANCER RESEARCH, 2005, 65 (14) : 6245 - 6254
  • [3] Human glypican-3 promotes hepatocellular carcinoma progression via induction of epithelial-mesenchymal transition
    Ogunwobi, Olorunseun O.
    Trinh, Thu L.
    Liu, Chen
    CANCER RESEARCH, 2012, 72
  • [4] Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
    Noriyuki Akutsu
    Hiroyuki Yamamoto
    Shigeru Sasaki
    Hiroaki Taniguchi
    Yoshiaki Arimura
    Kohzoh Imai
    Yasuhisa Shinomura
    World Journal of Gastroenterology, 2010, 16 (28) : 3521 - 3528
  • [5] Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
    Akutsu, Noriyuki
    Yamamoto, Hiroyuki
    Sasaki, Shigeru
    Taniguchi, Hiroaki
    Arimura, Yoshiaki
    Imai, Kohzoh
    Shinomura, Yasuhisa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (28) : 3521 - 3528
  • [6] Glypican-3, in conjunction with MMPs and wnt signaling molecules, plays an important role in the progression of hepatocellular carcinoma
    Miyamoto, Chie
    Yamamoto, Hiroyuki
    Sasaki, Shigeru
    Akutsu, Noriyuki
    Taniguchi, Hiroaki
    Miyamoto, Nobuki
    Nosho, Katsuhiko
    Maehata, Tadateru
    Yamashita, Kentaro
    Adachi, Yasushi
    Arimura, Yoshiaki
    Itch, Fumio
    Imai, Kohzoh
    Shinomura, Yasuhisa
    GASTROENTEROLOGY, 2008, 134 (04) : A466 - A466
  • [7] Modulation of YrdC promotes hepatocellular carcinoma progression via MEK/ERK signaling pathway
    Huang, Shigiong
    Zhu, Peng
    Sun, Bao
    Guo, Jun
    Zhou, Honghao
    Shu, Yan
    Li, Qing
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [8] Glypican-3 as a serum marker for hepatocellular carcinoma
    Capurro, M
    Filmus, J
    CANCER RESEARCH, 2005, 65 (01) : 372 - 372
  • [9] Upregulation of Glypican-3 in Human Hepatocellular Carcinoma
    Beppu, Tetsuya
    Suzuki, Masahiro
    Sugimoto, Kazushi
    Tanaka, Junnichiro
    Tameda, Masahiko
    Inagaki, Yuji
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Yamamoto, Norihiko
    Uchida, Kazuhiko
    Takase, Koujiro
    Shiraki, Katsuya
    GASTROENTEROLOGY, 2012, 142 (05) : S972 - S972
  • [10] Glypican-3 is overexpressed in human hepatocellular carcinoma
    Sung, YK
    Hwang, SY
    Park, MK
    Farooq, M
    Han, IS
    Bae, HI
    Kim, JC
    Kim, M
    CANCER SCIENCE, 2003, 94 (03): : 259 - 262
12345